The great need to overcome osimertinib resistance in advanced non-small cell lung cancer: from combination strategies to fourth-generation tyrosine kinase inhibitors.

Subjects

Subjects :

NON-small-cell lung carcinoma
PROTEIN-tyrosine kinase inhibitors
OSIMERTINIB

Details

Language :

English

ISSN :

2234943X

Database :

Complementary Index

Journal :

Frontiers in Oncology

Publication Type :

Academic Journal

Accession number :

175152415

Full Text :

https://doi.org/10.3389/fonc.2023.1308460